We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Photodynamic Therapy (PDT) Versus Transpupillary Thermotherapy (TTT) in Occult Choroidal Neovascularization (CNV) in Age-related Macular Degeneration (AMD)

This study has been terminated.
(Difficulties in recruiting patients)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00347906
First Posted: July 4, 2006
Last Update Posted: January 12, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University Hospital, Linkoeping
  Purpose
The purpose of this study is to compare the effect of PDT and TTT for the treatment of subfoveal occult CNV in age-related macular degeneration.

Condition Intervention
Age-Related Macular Degeneration Procedure: laser treatment

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Official Title: Photodynamic Therapy Versus Transpupillary Thermotherapy in Occult CNV in Age-related Macular Degeneration

Resource links provided by NLM:


Further study details as provided by University Hospital, Linkoeping:

Study Start Date: November 2003
Estimated Study Completion Date: September 2005
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   55 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • > 55 years of age,
  • Subfoveal occult only CNV due to AMD,
  • < 4 disc areas or > 4 disc areas
  • VA < 0.4

Exclusion Criteria:

  • Sign of classic CNV,
  • CNV in other diagnoses than AMD,
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00347906


Sponsors and Collaborators
University Hospital, Linkoeping
Investigators
Principal Investigator: Christina I Frennesson, MD, PhD Linkoeping University
  More Information

ClinicalTrials.gov Identifier: NCT00347906     History of Changes
Other Study ID Numbers: Dnr 00052
First Submitted: July 3, 2006
First Posted: July 4, 2006
Last Update Posted: January 12, 2010
Last Verified: November 2003

Additional relevant MeSH terms:
Macular Degeneration
Choroidal Neovascularization
Retinal Degeneration
Retinal Diseases
Eye Diseases
Choroid Diseases
Uveal Diseases
Neovascularization, Pathologic
Metaplasia
Pathologic Processes